Scientia Advisors in the News

---

Publications

---

Press Releases

---

Events

---

Luminary Insights

---

Media Contact

---

Scientia Advisors in the News

Advances in Personalized Medicine

In this special report, Bio*IT World spotlights a group of six organizations and thought leaders pushing new avenues in the vast convoluted landscape of personalized genetics and medicine. Scientia Advisors' managing partner, Harry Glorikian, opens the report with some refreshingly candid opinions summarized in an article entitled Turning the Titanic. In this interview-based article, Harry Glorikian comments on the uptake of personalized medicine and what it means for pharma. Also featured in this Bio*IT World special report are Gene Network Sciences' co-founder Iya Khalil, George Mason University's Chip Petricoin, Navigenics' co-founder Dietrich Stephan, Rules-Based Medicine's CEO Craig Benson, and PricewaterhouseCoopers' Mike Mentesana.

Advances in Personalized Medicine
and
Turning the Titanic